Tenofovir versus entecavir for children and adults with chronic hepatitis B

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To evaluate the benefits and harms of tenofovir versus entecavir in children and adults with chronic hepatitis B.

This is a protocol.

Published:

8 September 2023

Authors:

Li M, Yao L, Qin Y, Li Y, Lu M, Ma M, Yang M, Guo K, Wang Q, Zhang Z, Zhu L, Li X, Yang K

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Li M, Yao L, Qin Y, Li Y, Lu M, Ma M, Yang M, Guo K, Wang Q, Zhang Z, Zhu L, Li X, Yang K. Tenofovir versus entecavir for children and adults with chronic hepatitis B (Protocol). Cochrane Database of Systematic Reviews 2023, Issue 9. Art. No.: CD015642. DOI: 10.1002/14651858.CD015642.